AtriCure, Inc. (NASDAQ:ATRC) Q3 2023 Earnings Call Transcript November 1, 2023 AtriCure, Inc. beats earnings expectations. Reported EPS is $-0.2, expectations were $-0.3. Operator: Good afternoon, and welcome to AtriCure’s Third Quarter 2023 Earnings Conference Call. At this time, all participants are in listen-only mode. We will be facilitating a question-and-answer session towards the end […]
Operator: Good afternoon, and welcome to AtriCure s Second Quarter 2023 Earnings Conference Call. At this time, all participants are in listen-only mode.
AtriCure, Inc. , a leading innovator in surgical treatments and therapies for atrial fibrillation , left atrial appendage management and post-operative pain management, today announced that the. | April 19, 2023
AtriCure Inc. (NASDAQ:NASDAQ:ATRC) Q1 2022 Results Conference Call May 3, 2022 04:30 PM ET Company Participants Marissa Bych - Gilmartin Group Michael Carrel - President, CEO Angela Wirick.